Recursion Pharmaceuticals CEO sells 301,800 in stock
| BPGIX Fund | USD 24.99 0.21 0.85% |
Slightly above 51% of Boston Partners' investor base is interested to short. The analysis of overall sentiment of trading Boston Partners Global mutual fund suggests that many investors are impartial at this time. Boston Partners' investing sentiment can be driven by a variety of factors including economic data, Boston Partners' earnings reports, geopolitical events, and overall market trends.
Boston |
Recursion Pharmaceuticals CEO sells 301,800 in stock
Read at investing.com
 |
Boston Partners Fundamental Analysis
We analyze Boston Partners' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boston Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boston Partners based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Three Year Return
Three Year Return Comparative Analysis
Boston Partners is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
Boston Partners Global Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Boston Partners mutual fund to make a market-neutral strategy. Peer analysis of Boston Partners could also be used in its relative valuation, which is a method of valuing Boston Partners by comparing valuation metrics with similar companies.
Peers
Boston Partners Related Equities
| BPGSX | Rbb Fund | 0.93 | ||||
| WPGTX | Wpg Partners | 0.27 | ||||
| BPAIX | Boston Partners | 0.17 | ||||
| BPAVX | Boston Partners | 0.17 | ||||
| WPGSX | Rbb Fund | 0.16 | ||||
| OPTCX | Rbb Fund | 0.10 | ||||
| BGLSX | Boston Partners | 0.00 | ||||
| BGRSX | Boston Partners | 0.00 | ||||
| WPGHX | Wpg Partners | 0.28 | ||||
| BELSX | Boston Partners | 0.34 |
Other Information on Investing in Boston Mutual Fund
Boston Partners financial ratios help investors to determine whether Boston Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Partners security.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |